HIV/AIDS activists have sharply criticized proposed cuts to Bush-era program
FDA approved breakthrough preventative drug lenacapavir earlier this month
Experts say success could inhibit development of HIV vaccine
Experts discuss everything from PrEP access to blood donation
Gilead announces 99.9% of participants in trial were HIV negative
Once every six months injectable HIV prevention drug being tested
